NMRD240621P5000
- 0.00
- 0.000.00%
Nemaura Medical Newsroom
Nemaura Medical Restructures Finances, Board Members Change
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively BuyingThe Dow Jones index closed lower by over 150 points on Tuesday. When insiders purchase or sell shares
Crude Oil Gains Over 3%; US Manufacturing Activity Contracts For 14th Consecutive Month
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 150 points on Wednesday. The Dow traded down 0.79% to 37,417.28 while the NASDAQ fell 1.01% to 14,616.58. The
Dow Dips Over 100 Points Ahead Of Fed Minutes; UniFirst Shares Fall After Q1 Results
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.35% to 37,584.32 while the NASD
Nemaura Medical's Board Of Directors And Management Team Have Made The Strategic Decision To Accept Nasdaq's Determination To Delist Nemaura Medical And Move To The OTC Markets
Nemaura Medical's Board Of Directors And Management Team Have Made The Strategic Decision To Accept Nasdaq's Determination To Delist Nemaura Medical And Move To The OTC Markets
Important Update on Listing Status and Strategic Direction
January 3, 2024Important Update on Listing Status and Strategic DirectionLoughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) — Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a d
Buy Rating Affirmed for Nemaura Medical on SugarBEAT Prospects and Market Expansion
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersShattuck Labs (NASDAQ:STTK) shares increased by 92.9% to $4.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $172.9 million. Reshape Lifesciences (NA
Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K
Nemaura Medical Announced That The Nasdaq Hearings Panel Granted The Company's Request For Continued Listing Under An Exception, Which Ultimately Expires On April 1 2024 - 8K
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
December 13, 2023Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionLoughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) — Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura Medical" or the "Compan
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ:NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSILO Pharma (NASDAQ:SILO) shares increased by 36.2% to $2.22 during Tuesday's pre-market session. The company's market cap stands at $6.9 million. TRACON Pharma (NASDAQ:TCON) shares increased b
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNGM Biopharmaceuticals (NASDAQ:NGM) stock moved upwards by 11.5% to $0.7 during Monday's after-market session. This security traded at a volume of 109.4K shares come close, making up 23.4% of i
Nemaura Medical First Half 2024 Earnings: US$0.13 Loss per Share (Vs US$0.33 Loss in 1H 2023)
Nemaura Medical Rolls Out Metabolic Health Program in UK
Nemaura Medical (NMRD) said Tuesday that it has launched a program in the UK that aims to advance personalized weight management strategies by integrating continuous glucose monitoring with its behavi
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination With GLP-1 Weight Loss Drugs
November 14, 2023Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsCompany CEO to discuss development at 1pm EST on 15th November 202
Nemaura Medical Reports Cash And Cash Equivalents At September 30, 2023 Were ~$4.4M
Nemaura Medical Reports Cash And Cash Equivalents At September 30, 2023 Were ~$4.4M
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable,
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAtreca (NASDAQ:BCEL) shares moved upwards by 54.2% to $0.42 during Wednesday's after-market session. This security traded at a volume of 6.3 million shares come close, making up 485.4% of its a
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).The smallest co